LEVETIRACETAM IN TREATMENT OF EPILEPSY, OWN EXPERIENCE OF APPLICATION IN ADULT PATIENTS
Basic properties of Levetiracetam (LEV) were described and own experience of its application at the dose of 500–4000 mg/day in 95 patients at the age of 17–69 years (mean age 34 ± 13 years) with various epileptic syndromes was analyzed. The overall effect of LEV made 69.1%, remission at least a year...
Main Author: | G. G. Toropina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2017-05-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1868 |
Similar Items
-
Efficacy of generic levetiracetam (epiterra) in monotherapy for epilepsy in adult patients: preliminary results
by: V. A. Karlov, et al.
Published: (2015-03-01) -
Efficacy assessment of levetiracetam monotherapy in newly-diagnosed epilepsy in adults using epileptiform activity index
by: V. A. Karlov, et al.
Published: (2020-09-01) -
DIAGNOSTIC DIFFICULTIES IN PATIENTS WITH JUVENILE MYOCLONIC EPILEPSY
by: Cemile Haki, et al.
Published: (2020-12-01) -
THE INCIDENCE OF JUVENILE MYOCLONIC EPILEPSY AND ANALYSIS OF ITS THERAPY ACCORDING TO THE DATA OF THE “EPICENTER” (VOLGOGRAD)
by: O. V. Belyaev, et al.
Published: (2015-06-01) -
JUVENILE MYOCLONIC EPILEPSY: FOCUS ON THE USE OF TOPIRAMATE (LITERATURE REVIEW AND OWN DATA)
by: K. Yu. Mukhin, et al.
Published: (2017-08-01)